. FDA Greenlights First Drug for Agitation Related to Alzheimer Disease. JAMA. 2023 Jun 13;329(22):1907. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.